Cover Story
There is a quiet, profound tension in the rooms where cancer is treated. It is a space defined by a desperate balancing act. On one side of the scale is the undeniable necessity to eradicate a rapidly mutating, deeply adaptable disease.
Listing
Dr. Stanley T. Lewis: The Quiet Revolutionary of Lytic Peptides
There is a distinct type of silence in a hospital room after the doctor leaves. It is the silence of ...
The Antisense Architect: Dr. Stanley T. Crooke’s Legacy in Biotechnology
Dr. Stanley T. Crooke’s (Executive Chairman, Ionis Pharmaceuticals Inc.) story is one of a visionary who transformed the landscape of biotechnology. His ...
The AI Alchemist: Michelle Chen Is Writing the Code for Future Medicines
Traditional drug discovery is slow, costly, and often fails. Insilico Medicine’s Chief Business Officer, trained in biology and mentored by ...
Yuji Otsuki: Revolutionizing Oncology with Next-Generation Anticancer Drugs
“Hope is the foundation of the human spirit, and it’s what drives us to fight even the most daunting battles.” ...